Global Cord Blood Corp

Global Cord Blood Corp

CO - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$400.08M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Global Cord Blood CorpGlobal Cord Blood Corp1.5-61%0.30.1
$52.96

Current Fair Value

1672.6% upside

Undervalued by 1672.6% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$400.08 Million
Enterprise Value$-578,347,546.00
Earnings per Share$4.12
Beta-0.04
Outstanding Shares121,763,000

Return

Return on Equity61.43%ROE
Return on Assets35.12%
Return on Invested Capital47.77%

Valuation & Multiples

P/E Ratio1.54P/E Ratio
PEG-7.07PEG
Price to Sales0.3Price to Sales
Price to Book Ratio0.5Price to Book Ratio
Enterprise Value to Revenue-0.47
Enterprise Value to EBIT-0.97
Enterprise Value to Net Income-2
Total Debt to Enterprise-0.13
Debt to Equity0.09Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Global Cord Blood Corp

1,202 employees
CEO: Ting Zheng

Global Cord Blood Corporation, headquartered in Central, Hong Kong, primarily offers umbilical cord blood preservation and related support services within the People's Republic of China. The company's operations include the comprehensive...

Global Cord Blood Insider Information FAQ

In the latest 13F quarter on Stockcircle, 3 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.